Aerospace Has Two Kinds of AI Assurance. Agentic Systems Need a Third.

Two assurance regimes, one gap between them

Airbus is flying Mistral AI on an A350-1000 to automate taxi and landing sequences, with the stated goal of cutting pilot workload rather than replacing the flight crew, and FAA and EASA certification review is already underway InsideFlyer. Weeks later the two agencies shared a stage at Commercial UAV Expo 2026, a visible signal that they are converging on how to oversee autonomous and AI-enabled aircraft systems MarketScale. Around the same time, a defense contract was awarded specifically for model health monitoring and explainable AI, an early sign that at least one regulated sector is already funding continuous oversight of deployed models rather than treating approval as the finish line Unmanned Systems Technology.

That contract is worth pausing on, because it complicates a tidy argument. Aerospace and defense are not standing still on AI assurance. Model health monitoring watches a deployed system for drift, anomalous behavior, and degradation over time. It is a real answer to a real gap, and it is happening now, not hypothetically.

But model health monitoring answers a different question than the one buyers actually need answered before an agentic system goes live. It tells you when a model’s behavior has drifted from its baseline. It does not tell you whether an adversary can manipulate the agent’s decision loop, its inputs, its planning logic, its access to other tools and subsystems, before that drift ever shows up as an anomaly. That distinction matters because agentic systems don’t just respond to queries the way search engines or databases do. They observe, decide, and act continuously, chaining decisions across subsystems, which is the core reason passive-system security testing doesn’t transfer cleanly to them HSToday.

Three modes, not two

Regulated buyers are now dealing with three distinct assurance modes, and most procurement conversations still only budget for two. Certification asks whether the system performs its intended function within specified limits, the frame Airbus’s FAA and EASA review will apply. Model health monitoring asks whether a deployed system’s behavior stays within its established baseline over time. Neither asks whether the agent’s decision loop can be manipulated before certification sign-off or between monitoring checkpoints. That third mode, adversarial testing of the loop itself, is the one still missing from most supplier assurance packages.

Under ISO 42001, an organization’s AI management system is expected to address risk across the full lifecycle, not just at approval and not just through post-deployment monitoring. Buyers evaluating any AI-enabled platform, from Airbus’s landing trials to UAV systems under converging FAA and EASA oversight, should ask suppliers to name all three modes explicitly and show which one covers the gap between certification and monitoring.

The regulators sharing a stage at UAV Expo signals alignment on scope. The defense sector funding model health monitoring signals that continuous assurance is finally getting budget. Neither signals that anyone has yet tested whether the agent’s decision loop can be turned against itself before it acts.

---

Board record

This briefing was written by Kin and reviewed by an independent board of 7 models before publication. Ruling: CLEARED.

Seat	Reviewer	Finding
Chair · Editorial Judgment	Claude	cleared. The core argument—that adversarial testing of agentic decision loops is distinct from both certification and model health monitoring—is coherent and well-supported, though the claim that this third mo
Source & Claim Verification	Qwen · local	cleared. All factual claims are supported by citations, but the inclusion of the RVCE KCET Cutoff 2026 source seems irrelevant to the content and could be removed for clarity.
Regulatory & Framework Fidelity	Mistral	cleared. The briefing correctly identifies ISO 42001’s lifecycle risk requirement but does not explicitly map the proposed ‘third mode’ (adversarial testing) to specific clauses in ISO 42001, EU AI Act, or FDA
Technical Accuracy	Llama	cleared. The article accurately highlights the need for a third assurance mode for agentic AI systems beyond certification and model health monitoring, but some technical details and referenced sources could b
Bias, Balance & Hype Control	Gemini	cleared. The briefing effectively identifies and addresses a potential counterargument regarding model health monitoring, strengthening its core thesis rather than undermining it.
Novelty & Non-Duplication	Grok	held. Core thesis that agentic systems need adversarial decision-loop testing beyond certification and model-health monitoring is already stated in the cited HSToday piece; this is aerospace news-aggregatio
Validation	DeepSeek	cleared. The central claim that a third assurance mode for adversarial testing of the agentic decision loop is missing is logically sound and supported by cited expert analysis, but it is a forward-looking arg

Sources cited: 6. Validation challenges: 0. Review cost: about $0.04. Learn how these briefings are written and verified.